The antitumour efficacy of hesperidin vs. cisplatin against non‑small lung cancer cells A549 and H460 via targeting the miR‑34a/PD-L1/NF-κB signalling pathway
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2024-07-01
|
| Series: | Contemporary Oncology |
| Subjects: | |
| Online Access: | https://www.termedia.pl/The-antitumour-efficacy-r-nof-hesperidin-vs-cisplatin-against-r-nnon-small-lung-cancer-cells-r-nA549-and-H460-via-targeting-r-nthe-miR-34a-PD-L1-NF-B-signalling-r-npathway,3,54496,1,1.html |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832584797772316672 |
|---|---|
| author | Sherine M. Ibrahim Maryam S. Sayed Dina M. Abo-ElMatty Noha M. Mesbah Asmaa R. Abdel-Hamed |
| author_facet | Sherine M. Ibrahim Maryam S. Sayed Dina M. Abo-ElMatty Noha M. Mesbah Asmaa R. Abdel-Hamed |
| author_sort | Sherine M. Ibrahim |
| collection | DOAJ |
| format | Article |
| id | doaj-art-7c11e6873d904dbca684edb4e554cc39 |
| institution | Kabale University |
| issn | 1428-2526 1897-4309 |
| language | English |
| publishDate | 2024-07-01 |
| publisher | Termedia Publishing House |
| record_format | Article |
| series | Contemporary Oncology |
| spelling | doaj-art-7c11e6873d904dbca684edb4e554cc392025-01-27T11:16:54ZengTermedia Publishing HouseContemporary Oncology1428-25261897-43092024-07-0128213014810.5114/wo.2024.14164854496The antitumour efficacy of hesperidin vs. cisplatin against non‑small lung cancer cells A549 and H460 via targeting the miR‑34a/PD-L1/NF-κB signalling pathwaySherine M. IbrahimMaryam S. SayedDina M. Abo-ElMattyNoha M. MesbahAsmaa R. Abdel-Hamedhttps://www.termedia.pl/The-antitumour-efficacy-r-nof-hesperidin-vs-cisplatin-against-r-nnon-small-lung-cancer-cells-r-nA549-and-H460-via-targeting-r-nthe-miR-34a-PD-L1-NF-B-signalling-r-npathway,3,54496,1,1.htmlnon-small cell lung cancer hesperidin mir-34a apoptosis nf-κb cisplatin pdl-1 |
| spellingShingle | Sherine M. Ibrahim Maryam S. Sayed Dina M. Abo-ElMatty Noha M. Mesbah Asmaa R. Abdel-Hamed The antitumour efficacy of hesperidin vs. cisplatin against non‑small lung cancer cells A549 and H460 via targeting the miR‑34a/PD-L1/NF-κB signalling pathway Contemporary Oncology non-small cell lung cancer hesperidin mir-34a apoptosis nf-κb cisplatin pdl-1 |
| title | The antitumour efficacy
of hesperidin vs. cisplatin against
non‑small lung cancer cells
A549 and H460 via targeting
the miR‑34a/PD-L1/NF-κB signalling
pathway |
| title_full | The antitumour efficacy
of hesperidin vs. cisplatin against
non‑small lung cancer cells
A549 and H460 via targeting
the miR‑34a/PD-L1/NF-κB signalling
pathway |
| title_fullStr | The antitumour efficacy
of hesperidin vs. cisplatin against
non‑small lung cancer cells
A549 and H460 via targeting
the miR‑34a/PD-L1/NF-κB signalling
pathway |
| title_full_unstemmed | The antitumour efficacy
of hesperidin vs. cisplatin against
non‑small lung cancer cells
A549 and H460 via targeting
the miR‑34a/PD-L1/NF-κB signalling
pathway |
| title_short | The antitumour efficacy
of hesperidin vs. cisplatin against
non‑small lung cancer cells
A549 and H460 via targeting
the miR‑34a/PD-L1/NF-κB signalling
pathway |
| title_sort | antitumour efficacy of hesperidin vs cisplatin against non small lung cancer cells a549 and h460 via targeting the mir 34a pd l1 nf κb signalling pathway |
| topic | non-small cell lung cancer hesperidin mir-34a apoptosis nf-κb cisplatin pdl-1 |
| url | https://www.termedia.pl/The-antitumour-efficacy-r-nof-hesperidin-vs-cisplatin-against-r-nnon-small-lung-cancer-cells-r-nA549-and-H460-via-targeting-r-nthe-miR-34a-PD-L1-NF-B-signalling-r-npathway,3,54496,1,1.html |
| work_keys_str_mv | AT sherinemibrahim theantitumourefficacyofhesperidinvscisplatinagainstnonsmalllungcancercellsa549andh460viatargetingthemir34apdl1nfkbsignallingpathway AT maryamssayed theantitumourefficacyofhesperidinvscisplatinagainstnonsmalllungcancercellsa549andh460viatargetingthemir34apdl1nfkbsignallingpathway AT dinamaboelmatty theantitumourefficacyofhesperidinvscisplatinagainstnonsmalllungcancercellsa549andh460viatargetingthemir34apdl1nfkbsignallingpathway AT nohammesbah theantitumourefficacyofhesperidinvscisplatinagainstnonsmalllungcancercellsa549andh460viatargetingthemir34apdl1nfkbsignallingpathway AT asmaarabdelhamed theantitumourefficacyofhesperidinvscisplatinagainstnonsmalllungcancercellsa549andh460viatargetingthemir34apdl1nfkbsignallingpathway AT sherinemibrahim antitumourefficacyofhesperidinvscisplatinagainstnonsmalllungcancercellsa549andh460viatargetingthemir34apdl1nfkbsignallingpathway AT maryamssayed antitumourefficacyofhesperidinvscisplatinagainstnonsmalllungcancercellsa549andh460viatargetingthemir34apdl1nfkbsignallingpathway AT dinamaboelmatty antitumourefficacyofhesperidinvscisplatinagainstnonsmalllungcancercellsa549andh460viatargetingthemir34apdl1nfkbsignallingpathway AT nohammesbah antitumourefficacyofhesperidinvscisplatinagainstnonsmalllungcancercellsa549andh460viatargetingthemir34apdl1nfkbsignallingpathway AT asmaarabdelhamed antitumourefficacyofhesperidinvscisplatinagainstnonsmalllungcancercellsa549andh460viatargetingthemir34apdl1nfkbsignallingpathway |